Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 60/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

Thursday, January 26, 2023 1 min read
Key Takeaway: Dr. Reddy's Laboratories has published its unaudited financial results for the quarter and nine months ended December 31, 2022. This announcement complies with the Securities and Exchange Board of India regulations regarding disclosure requirements. The results were disseminated through newspaper advertisements in Business Standard and Andhra Prabha on January 26, 2023, ensuring transparency with stakeholders. The company continues to demonstrate its commitment to disclosure and record-keeping.

Market Sentiment Analysis

POSITIVE FACTORS

  • The company is maintaining transparency through public disclosures.
  • Dr. Reddy's Laboratories is actively updating its financial performance.
  • The publication of unaudited financial results reflects ongoing compliance.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
Sub: Copies of newspaper advertisement regarding unaudited
financial results for the quarter and nine months ended December 31, 2022
Pursuant to Regulation 47 of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed copies of newspaper
advertisement regarding the unaudited financial results of the company for the quarter and nine months ended December 31, 2022, as published
in Business Standard and Andhra Prabha on January 26, 2023.
This is for your information and records
For Dr. Reddy's Laboratories Limited
/s/ K Randhir Singh
K Randhir Singh
Company Secretary, Compliance Officer and Head-CSR

Frequently Asked Questions

What is the Scrip Code for Dr. Reddy's on NSE?

The Scrip Code for Dr. Reddy's on NSE is DRREDDY-EQ.

Where can I find Dr. Reddy's NYSE stock code?

Dr. Reddy's stock code on NYSE is RDY.

When were the unaudited financial results published?

The unaudited financial results were published on January 26, 2023.

Which regulations govern the financial result disclosures?

The disclosures are governed by SEBI's Listing Obligations and Disclosure Requirements.

Who is the Company Secretary for Dr. Reddy's?

K Randhir Singh is the Company Secretary for Dr. Reddy's Laboratories Limited.

Tags: RDY Viatris Investor Conferences Healthcare Dr. Reddy's Laboratories financial results quarterly earnings SEBI regulations
Last updated: Jan 26, 2023